Black Mirror and Brain Pacemakers: The Future Is Closer Than You Think
I recently watched the first episode of the new Black Mirror season—and I haven’t stopped thinking about it.
In the episode, a woman’s life is saved by a neural implant, but the catch is chilling: she essentially signs a contract to stay alive, subject to price hikes and invasive marketing directly into her thoughts. As the costs spiral, her family is left facing an impossible decision.
Fiction? Yes. Far-fetched? Not really.
As a recently retired neuroradiologist from the Barrow Neurological Institute—one of the busiest centers in the U.S. for deep brain stimulation—I’ve seen firsthand how technology can transform lives. Patients with Parkinson’s, once imprisoned by tremors, now regain independence through what we call “brain pacemakers.”
We are living in the early days of mind-machine interfaces. Elon Musk’s Neuralink just demonstrated a quadriplegic patient controlling a computer with his thoughts. The gap between Black Mirror and bedside is shrinking.
But here’s the question the episode so powerfully raises: What happens when life-saving tech becomes a toll road for profit?
Innovation must be sustainable. But it must also be compassionate. I call this compassionate capitalism—the idea that we can drive advancement while protecting the vulnerable. The line between progress and exploitation is thin. And we are standing on it now.
We need to talk about the ethics of pricing, ownership, and control in a world where our brains are becoming endpoints in the system. Notably, this type of expensive medical innovation is not limited to neuroscience. There are a myriad of examples in healthcare where the cost of innovation literally leads to life and death decisions.
What do you think? How do we strike the balance between profit and access in the next wave of healthcare innovation?
#BlackMirror #Neurotechnology #InnovationEthics #Healthcare #DeepBrainStimulation #Neuralink #CompassionateCapitalism #FutureOfCare
President, Health Quality Advisors LLC
5moGreat post Alan Pitt Keep at it.
Healthcare Innovation Solutions and Partnerships
5moYou always make me think so hard, and I love it. Thanks Alan!
Business Development Executive
5moIt's a thought provoking question, Alan. I participate in conversations with employers and their consultants about "high-cost claimants" on a regular basis. I see a myriad of causes. 1) prolonged life-sustaining treatment enabled by a) clinical/Rx advancements (CA treatments, etc), b) following a proven clinical protocol (e.g. sepsis), c) grasping to hope. 2) Avoidable complications. My context for these discussions is with employers that are paying for all this. People like to think healthcare rationing discussions aren't occurring. Our advancements are incredibly expensive.
CEO at American Red Cross
5moInsightful, thank you Alan. I would be happy to discuss this topic with you.
Healthcare/Life Science Real Estate Specialist, Community Supporter
5moYou are always thought provoking and creating conversations Alan Pitt !